Abstract:Neuroendocrine tumors of the thymus (NETTs) were rare neoplasms, and were classified into 4 histological entities: typical and atypical carcinoids (ATCs), small-cell and large-cell neuroendocrine carcinomas. Studies have shown the biological behavior, survival and recurrence between these types were divergent, but the clinical features and optimal treatment modalities still remain controversial. We aim to evaluate the clinicopathological characteristics and survival outcomes of in ATCs patients, especially the value of postoperative radiotherapy and R0 resection. We used the SEER database [1973-2014] to identify patients who were diagnosed as ATCs. The clinic-pathologic data as well as the histologic features were recorded. Multivariate analyses by use of the Cox proportional hazards model were performed to evaluate the effect of covariate on OS. Kaplan-Meier survival curves were used to describe survival probability of OS. A total of 39 patients with primary ATCs were included. The median age was 57, the incidence was three times higher for men (29, 74.4%) than for women(10,25.6%). ATCs were more likely larger in size (mean 9.1 cm, SD=3.9). R0 resection was performed for 46.9% patients. 19 patients received postoperative radiotherapy. The mean survival (MS) time was 63.1 months. The 5-yr OS was 55.7%. OS was not significantly different between patients treated with postoperative radiotherapy (yes vs no, p=0.540), but significantly between patients treated with R0 resection (yes vs no, 5-yr OS: 80.8% vs 37.1%; p=0.012). For those received R0 resection, there were no significant differences in OS between patients undergone adjuvant radiotherapy (yes vs no, 5-yr OS:80.0% vs 57.10%; p=0.460). However, adjuvant radiotherapy showed a trend in increasing survival for patients who received R1/R2 resection (yes vs no, 5-yr OS: 75.0% vs 32.10%; p=0.152). Univariate Analysis showed female (HR=10.038, p=0.000), age older than sixty (HR=0.017, p=0.017), distant metastases (HR=1.470, p=0.024) and R1/R2 resection (HR=4.939, p=0.020) were independent risk factors for survival. Multivariable analysis showed female was associated with much higher risk of all-cause mortality (HR=5.711, p=0.025) compared with male. Patients with distant metastases had worse OS than non-metastases patients (HR=1.879, p=0.030), postoperative radiotherapy wasn’t associated with longer OS (HR=1.579, p=0.484). To our knowledge, this is the first report investigating the epidemiological factors and survival trends in ATCs based the SEER database. We suggest that ATCs primarily afflict males, usually in the fifth decade of life. R0 surgical resection is recommended for ATCs. Patients might benefit from R1/R2 resection plus adjuvant radiotherapy, and have an OS approximate to those who accept R0 resection alone. However, the role of postoperative radiotherapy for ATCs warrant prospective evaluation in clinical trials.

Oncological Results and Recurrent Risk Factors Following Abdominal Radical Trachelectomy (ART): an Updated Series of 333 Patients

Comparisons of Vaginal and Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer: Preliminary Results of a Multi-Center Research in China.

The survival rate of abdominal radical trachelectomy versus abdominal radical hysterectomy for stage IB1 cervical cancer ≥2 cm

Surgical and Pathological Outcomes of Abdominal Radical Trachelectomy Versus Hysterectomy for Early-Stage Cervical Cancer.

Abdominal radical trachelectomy: Is it safe for IB1 cervical cancer with tumors ≥ 2 cm?

Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients.

The Survival Rate and Surgical Morbidity of Abdominal Radical Trachelectomy Versus Abdominal Radical Hysterectomy for Stage IB1 Cervical Cancer

Reproductive and obstetric outcomes after abdominal radical trachelectomy (ART) for patients with early-stage cervical cancers in Fudan, China.

Abdominal Radical Trachelectomy (ART) for Cervical Cancer:How Many Patients May Be Eligible for Fertility Preservation

Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma.

A 10-Year Austrian Single-Center Experience

The oncological and obstetric results of radical trachelectomy as a fertility-sparing therapy in early-stage cervical cancer patients

Surgical, oncologic, and obstetric outcomes of radical trachelectomy in early-stage cervical cancer: results from a retrospective cohort study at Brazil National Cancer Institute

Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis

Menstrual Pattern after Abdominal Radical Trachelectomy

An update of oncologic and obstetric outcomes of radical trachelectomy for early-stage cervical cancer: The need for further minimally invasive treatment

Curative Effect of Laparoscopic-Assisted Vaginal Radical Trachelectomy Combined with Pelvic Lymph Node Dissection on Early-Stage Cervical Cancer

Decreased pregnancy rate per embryo transfer in women undergoing assisted reproductive technology after abdominal trachelectomy: A retrospective study

The Value of Postoperative Radiation Therapy in Atypical Thymic Carcinoid Remains Unclear: A Population-Based Study

Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer

Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer